In the complaint filed by the law firm Robbins Geller Rudman & Dowd, investors claim that between April 24, 2019, and July 24, 2019, Align Technology made false statements that emphasized the company’s growth in China. Align Technology allegedly described its Chinese operations as a “huge market opportunity” with “tremendous growth.”
As a result of Align Technology’s statements on its performance in China, its common stock inflated to more than $330 per share during the time frame mentioned above, according to the lawsuit.
However, when the market closed on July 24, 2019, Align Technology reported declining sales volumes for the second quarter of that year. Align Technology CEO said the issues were “primarily due to softness in China related to a tougher consumer environment.”
After Align Technology released its earnings report, the company’s stock declined more than 27 percent, closing at $275.16.
More articles on dental:
Pennsylvania oral surgeon to pay $46K to avoid healthcare fraud case
Align Technology chief is 2nd most ‘overpaid’ CEO, report finds
California oral surgeon charged with human trafficking
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
